1. 16/#430 Phase 2 results of relacorilant + nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer with and without prior bevacizumab. (4th December 2022) Authors: Colombo, Nicoletta; Gorp, Toon Van; Matulonis, Ursula; Oaknin, Ana; Grisham, Rachel; Fleming, Gini; Olawaiye, Alexander; Tudor, Iulia Cristina; Pashova, Hristina; Lorusso, Domenica Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-LBA-325-ESGO Patients with newly diagnosed ovarian cancer treated with maintenance rucaparib: exploratory biomarker analysis from the phase 3 ATHENA-MONO study (GOG-3020/ENGOT-ov45; NCT03522246). (27th October 2022) Authors: Oaknin, Ana; Kristeleit, Rebecca S; Mahdi, Haider S; Lim, Myong Cheol; de Vivo, Rocco; Salinas, Erin A; Wilson, Michelle K; Liontos, Michalis; Santin, Alessandro D; Provencher, Diane M; Demirkiran, Fuat; Willmott, Lyndsay J; Chudecka-Głaz, Anita M; Herzog, Thomas J; Beiner, Mario E; Copeland, Lar... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-1009-ESGO Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the GARNET study. (20th October 2022) Authors: Tinker, Anna V; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David M; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan E; Pikiel, Johanna; Mirza, Mansoor R.; Duan, Tao; Zildjian, Sybil; Zografos, Eleftherios; Vener... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2022-RA-1074-ESGO AGO-OVAR 2.29 (ENGOT-ov34): atezolizumab in combination with bevacizumab and chemotherapy vs bevacizumab and chemotherapy in recurrent ovarian cancer. (20th October 2022) Authors: Harter, Philipp; Marmé, Frederik; Pietzner, Klaus; Reuss, Alexander; Ray-Coquard, Isabelle; Redondo, Andrés; Oaknin, Ana; Jonuskiene, Goda; Lindemann, Kristina; Kurzeder, Christian; Huober, Jens; van Nieuwenhuysen, Els; Henry, Stephanie; Marth, Christian; Tsibulak, Irina; Cron, Nadin; Pautier, Pa... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2022-RA-1144-ESGO Management of immune-related adverse events in patients with solid tumours treated with dostarlimab in the GARNET study. (20th October 2022) Authors: Berton, Dominique; Andre, Thierry; Oaknin, Ana; Moreno, Victor; Trigo, José; Curigliano, Giuseppe; Tinker, Anna V; Boni, Valentina; Barretina-Ginesta, Maria Pillar; Pikiel, Joanna; Pothuri, Bhavana; Mirza, Mansoor R; Panovcova, Petra; Duan, Tao; Dabrowski, Christine; Dabrowski, Christine; Zografo... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2022-RA-1194-ESGO Efficacy of dostarlimab in endometrial cancer by molecular subtype: a post hoc analysis of the GARNET study. (20th October 2022) Authors: Tinker, Anna V; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David M; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan E; Pikiel, Joanna; Mirza, Mansoor R; Duan, Tao; Han, Xinwei; Zildjian, Sybil; Zografos, Elefthe... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 2022-RA-1198-ESGO Post hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab. (20th October 2022) Authors: Tinker, Anna V; Sabatier, Renaud; Gravina, Adriano; Gilbert, Lucy; Brown, Jubilee; Samouëlian, Vanessa; Reade, Clare J; Mathews, Cara; Ellard, Susan; Banerjee, Susana; Barretina-Ginesta, Maria Pillar; Miller, Rowan; Leath, Charles; Pothuri, Bhavana; Duan, Tao; Han, Xinwei; Zografos, Eleftherios; ... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2022-RA-1297-ESGO A subgroup analysis of response rate by patient characteristics in patients with endometrial cancer receiving monotherapy dostarlimab in the GARNET trial. (20th October 2022) Authors: Oaknin, Ana; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David M; Kristeleit, Rebecca; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan E; Pikiel, Joanna; Miza, Mansoor R; Duan, Tao; Dong, Yuping; Zografos, Elefth... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2022-RA-1548-ESGO Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer. (20th October 2022) Authors: Vergote, Ignace; Mirza, Mansoor; Sehouli, Jalid; Lorusso, Domenico; Kose, Fatih; Cibula, David; Westermann, Anneke; Collins, Dearbhaile; Banerjee, Susana; Oaknin, Ana; Soumaoro, Ibrahima; Jain, Shweta; Monk, Bradley J Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 2022-RA-249-ESGO Overall survival results from ariel3: a phase 3 randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma. (20th October 2022) Authors: Coleman, Robert L; Oza, Amit M; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I; Clamp, Andrew R; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W; Gancedo, Margarita Amenedo; Fong, Peter C; Goh, Jeffrey C; O'Malley, David M; Goble,... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗